Developing a Tablet-Based Self-Persuasion Intervention Promoting Adolescent HPV Vaccination: Protocol for a Three-Stage Mixed-Methods Study

Jasmin A Tiro, Simon Craddock Lee, Emily G Marks, Donna Persaud, Celette Sugg Skinner, Richard L Street, Deborah J Wiebe, David Farrell, Wendy Pechero Bishop, Sobha Fuller, Austin S Baldwin, Jasmin A Tiro, Simon Craddock Lee, Emily G Marks, Donna Persaud, Celette Sugg Skinner, Richard L Street, Deborah J Wiebe, David Farrell, Wendy Pechero Bishop, Sobha Fuller, Austin S Baldwin

Abstract

Background: Human papillomavirus (HPV)-related cancers are a significant burden on the US health care system that can be prevented through adolescent HPV vaccination. Despite guidelines recommending vaccination, coverage among US adolescents is suboptimal particularly among underserved patients (uninsured, low income, racial, and ethnic minorities) seen in safety-net health care settings. Many parents are ambivalent about the vaccine and delay making a decision or talking with a provider about it. Self-persuasion-generating one's own arguments for a health behavior-may be particularly effective for parents who are undecided or not motivated to make a vaccine decision.

Objective: Through a 3-stage mixed-methods protocol, we will identify an optimal and feasible self-persuasion intervention strategy to promote adolescent HPV vaccination in safety-net clinics.

Methods: In Stage 1, we will define content for a tablet-based self-persuasion app by characterizing (1) parents' self-generated arguments through cognitive interviews conducted with parents (n=50) of patients and (2) parent-provider HPV vaccine discussions through audio recordings of clinic visits (n=50). In Stage 2, we will compare the effects of the four self-persuasion intervention conditions that vary by cognitive processing level (parents verbalize vs listen to arguments) and choice of argument topics (parents choose vs are assigned topics) on parental vaccine intentions in a 2 × 2 factorial design randomized controlled trial (n=160). This proof-of-concept trial design will identify which intervention condition is optimal by quantitatively examining basic self-persuasion mechanisms (cognitive processing and choice) and qualitatively exploring parent experiences with intervention tasks. In Stage 3, we will conduct a pilot trial (n=90) in the safety-net clinics to assess feasibility of the optimal intervention condition identified in Stage 2. We will also assess its impact on parent-provider discussions.

Results: This paper describes the study protocol and activities to date. Currently, we have developed the initial prototype of the tablet app for English- and Spanish-speaking populations, and completed Stage 1 data collection.

Conclusions: Our systematic collaboration between basic and applied behavioral scientists accelerates translation of promising basic psychological research into innovative interventions suitable for underserved, safety-net populations. At project's end, we plan to have a feasible and acceptable self-persuasion intervention that can affect key cancer disparities in the United States through prevention of HPV-related cancers.

Trial registration: ClinicalTrials.gov https://ichgcp.net/clinical-trials-registry/NCT02537756 and https://ichgcp.net/clinical-trials-registry/NCT02535845 (Archived by WebCite at http://www.webcitation.org/6e5XcOGXz and http://www.webcitation.org/6e5XfHoic, respectively).

Keywords: HPV vaccination; adolescents; intervention development; self-persuasion.

Conflict of interest statement

Conflicts of Interest: None declared.

Figures

Figure 1
Figure 1
Three-stage strategy for developing and refining a parent-targeted self-persuasion intervention on adolescent HPV vaccination.
Figure 2
Figure 2
Stage 1a objectives and Stage 2 trial design with tasks parents complete while using the tablet application.
Figure 3
Figure 3
Screenshots of tablet app in (a) English and (b) Spanish.

References

    1. Stokley S, Jeyarajah J, Yankey D, Cano M, Gee J, Roark J, Curtis RC, Markowitz L, Immunization Services Division‚ National Center for ImmunizationRespiratory Diseases‚ CDC. Centers for Disease ControlPrevention (CDC) Human papillomavirus vaccination coverage among adolescents, 2007-2013, and postlicensure vaccine safety monitoring, 2006-2014--United States. MMWR Morb Mortal Wkly Rep. 2014 Jul 25;63(29):620–624.
    1. Centers for Disease ControlPrevention (CDC) Recommendations on the use of quadrivalent human papillomavirus vaccine in males--Advisory Committee on Immunization Practices (ACIP), 2011. MMWR Morb Mortal Wkly Rep. 2011 Dec 23;60(50):1705–1708.
    1. Saslow D, Castle PE, Cox JT, Davey DD, Einstein MH, Ferris DG, Goldie SJ, Harper DM, Kinney W, Moscicki A, Noller KL, Wheeler CM, Ades T, Andrews KS, Doroshenk MK, Kahn KG, Schmidt C, Shafey O, Smith RA, Partridge EE, Gynecologic Cancer Advisory Group. Garcia F. American Cancer Society Guideline for human papillomavirus (HPV) vaccine use to prevent cervical cancer and its precursors. CA Cancer J Clin. 2007;57(1):7–28.
    1. Petrosky E, Bocchini JA, Hariri S, Chesson H, Curtis CR, Saraiya M, Unger ER, Markowitz LE, Centers for Disease ControlPrevention (CDC) Use of 9-valent human papillomavirus (HPV) vaccine: Updated HPV vaccination recommendations of the advisory committee on immunization practices. MMWR Morb Mortal Wkly Rep. 2015 Mar 27;64(11):300–304.
    1. Committee on Adolescent Health Care. ACOG Working Group on Immunization ACOG Committee Opinion No. 344: Human papillomavirus vaccination. Obstet Gynecol. 2006 Sep;108(3 Pt 1):699–705.
    1. US Department of Health and Human Services Increase the Vaccination Coverage Level of 3 Doses of Human Papillomavirus (HPV) Vaccine for Females and Males by Age 13 to 15 years. 2015. [2015-09-02]. .
    1. Bartlett JA, Peterson JA. The uptake of human papillomavirus (HPV) vaccine among adolescent females in the United States: A review of the literature. J Sch Nurs. 2011 Dec;27(6):434–446. doi: 10.1177/1059840511415861.
    1. Hughes CC, Jones AL, Feemster KA, Fiks AG. HPV vaccine decision making in pediatric primary care: A semi-structured interview study. BMC Pediatr. 2011;11:74. doi: 10.1186/1471-2431-11-74.
    1. Holman DM, Benard V, Roland KB, Watson M, Liddon N, Stokley S. Barriers to human papillomavirus vaccination among US adolescents: A systematic review of the literature. JAMA Pediatr. 2014 Jan;168(1):76–82. doi: 10.1001/jamapediatrics.2013.2752.
    1. Garcini LM, Galvan T, Barnack-Tavlaris JL. The study of human papillomavirus (HPV) vaccine uptake from a parental perspective: A systematic review of observational studies in the United States. Vaccine. 2012 Jun 29;30(31):4588–4595. doi: 10.1016/j.vaccine.2012.04.096.
    1. Allen JD, Othus Megan K D. Shelton RC, Li Y, Norman N, Tom L, del Carmen Marcela G Parental decision making about the HPV vaccine. Cancer Epidemiol Biomarkers Prev. 2010 Sep;19(9):2187–2198. doi: 10.1158/1055-9965.EPI-10-0217.
    1. Szilagyi PG, Schaffer S, Shone L, Barth R, Humiston SG, Sandler M, Rodewald LE. Reducing geographic, racial, and ethnic disparities in childhood immunization rates by using reminder/recall interventions in urban primary care practices. Pediatrics. 2002 Nov;110(5):e58.
    1. Szilagyi PG, Schaffer S, Barth R, Shone LP, Humiston SG, Ambrose S, Averhoff F. Effect of telephone reminder/recall on adolescent immunization and preventive visits: Results from a randomized clinical trial. Arch Pediatr Adolesc Med. 2006 Feb;160(2):157–163. doi: 10.1001/archpedi.160.2.157.
    1. Szilagyi PG, Humiston SG, Gallivan S, Albertin C, Sandler M, Blumkin A. Effectiveness of a citywide patient immunization navigator program on improving adolescent immunizations and preventive care visit rates. Arch Pediatr Adolesc Med. 2011 Jun;165(6):547–553. doi: 10.1001/archpediatrics.2011.73.
    1. Suh CA, Saville A, Daley MF, Glazner JE, Barrow J, Stokley S, Dong F, Beaty B, Dickinson LM, Kempe A. Effectiveness and net cost of reminder/recall for adolescent immunizations. Pediatrics. 2012 Jun;129(6):e1437–e1445. doi: 10.1542/peds.2011-1714.
    1. Fu LY, Bonhomme L, Cooper SC, Joseph JG, Zimet GD. Educational interventions to increase HPV vaccination acceptance: A systematic review. Vaccine. 2014 Apr 7;32(17):1901–1920. doi: 10.1016/j.vaccine.2014.01.091.
    1. Fiks AG, Grundmeier RW, Mayne S, Song L, Feemster K, Karavite D, Hughes CC, Massey J, Keren R, Bell LM, Wasserman R, Localio AR. Effectiveness of decision support for families, clinicians, or both on HPV vaccine receipt. Pediatrics. 2013 Jun;131(6):1114–1124. doi: 10.1542/peds.2012-3122.
    1. Chaiken S, Liberman A, Eagly A. Heuristic and systematic information processing within and beyond the persuasion context. In: Uleman JS, Bargh JA, editors. Unintended Thought. New York, NY: Guilford Press; 1989. pp. 212–252.
    1. Petty RE, Wegener DT. The Handbook of Social Psychology. 4 ed. New York, NY: McGraw-Hill; 1998. Attitude change: Multiple roles for persuasion variables; pp. 323–390.
    1. Stone J, Aronson E, Crain AL, Winslow MP, Fried CB. Inducing hypocrisy as a means of encouraging young adults to use condoms. Pers Soc Psychol Bull. 1994;20:116–128.
    1. Aronson E. The power of self-persuasion. Am Psychol. 1999;54:875–884.
    1. Baldwin AS, Rothman AJ, Vander Weg Mark W. Christensen AJ. Examining causal components and a mediating process underlying self-generated health arguments for exercise and smoking cessation. Health Psychol. 2013 Dec;32(12):1209–1217. doi: 10.1037/a0029937.
    1. Pierce RA, Stoltenberg CD. Increasing program persistence in professional weight loss programs involving cognitive self-persuasion. Prof Psychol Res Pr. 1990;21:210–215.
    1. Stice E, Marti CN, Spoor S, Presnell K, Shaw H. Dissonance and healthy weight eating disorder prevention programs: Long-term effects from a randomized efficacy trial. J Consult Clin Psychol. 2008 Apr;76(2):329–340. doi: 10.1037/0022-006X.76.2.329.
    1. Flay BR, Ryan KB, Best JA, Brown KS, Kersell MW, d'Avernas JR, Zanna MP. Are social-psychological smoking prevention programs effective? The Waterloo study. J Behav Med. 1985 Mar;8(1):37–59.
    1. Ryan RM, Deci EL. Self-determination theory and the facilitation of intrinsic motivation, social development, and well-being. Am Psychol. 2000 Jan;55(1):68–78.
    1. Ryan RM, Patrick H, Deci EL, Williams GC. Facilitating health behaviour change and its maintenance: Interventions based on self-determination theory. Eur Health Psychol. 2008;10:2–5.
    1. Williams GC, Niemiec CP, Patrick H, Ryan RM, Deci EL. The importance of supporting autonomy and perceived competence in facilitating long-term tobacco abstinence. Ann Behav Med. 2009 Jun;37(3):315–324. doi: 10.1007/s12160-009-9090-y.
    1. Craik FIM, Lockhart RS. Levels of processing: A framework for memory research. J Verbal Learning Verbal Behav. 1972;11:671–684.
    1. Greenwald AG, Albert RD. Acceptance and recall of improvised arguments. J Pers Soc Psychol. 1968 Jan;8(1):31–34.
    1. Kreuter MW, Strecher VJ, Glassman B. One size does not fit all: the case for tailoring print materials. Ann Behav Med. 1999;21(4):276–283.
    1. Skinner CS, Kreuter MW, Buchanan A. Adaptation of tailored intervention message libraries. Health Educ. 2003;103(4):221–229.
    1. Baldwin AS, Bruce CM, Tiro JA. Understanding how mothers of adolescent girls obtain information about the human papillomavirus vaccine: Associations between mothers' health beliefs, information seeking, and vaccination intentions in an ethnically diverse sample. J Health Psychol. 2013 Jul;18(7):926–938. doi: 10.1177/1359105312445078.
    1. Scarinci IC, Garcés-Palacio IC, Partridge EE. An examination of acceptability of HPV vaccination among African American women and Latina immigrants. J Womens Health (Larchmt) 2007 Oct;16(8):1224–1233. doi: 10.1089/jwh.2006.0175.
    1. Keenan K, Hipwell A, Stepp S. Race and sexual behavior predict uptake of the human papillomavirus vaccine. Health Psychol. 2012 Jan;31(1):31–34. doi: 10.1037/a0026812.
    1. Rollnick S, Miller WR, Butler CC. Motivational Interviewing in Health Care. New York, NY: Guildford Press; 2008.
    1. Burke BL, Arkowitz H, Menchola M. The efficacy of motivational interviewing: A meta-analysis of controlled clinical trials. J Consult Clin Psychol. 2003 Oct;71(5):843–861. doi: 10.1037/0022-006X.71.5.843.
    1. Diekema DS. Improving childhood vaccination rates. N Engl J Med. 2012 Feb 2;366(5):391–393. doi: 10.1056/NEJMp1113008.
    1. Cegala DJ. Emerging trends and future directions in patient communication skills training. Health Commun. 2006;20(2):123–129. doi: 10.1207/s15327027hc2002_3.
    1. Creswell JW, Klassen AC, Plano Clark VL, Smith KC. Best Practices for Mixed Methods Research in the Health Sciences. 2011. [2015-09-02].
    1. Pickens S, Boumbulian P, Anderson RJ, Ross S, Phillips S. Community-oriented primary care in action: A Dallas story. Am J Public Health. 2002 Nov;92(11):1728–1732.
    1. Tiro JA, Pruitt SL, Bruce CM, Persaud D, Lau M, Vernon SW, Morrow J, Skinner CS. Multilevel correlates for human papillomavirus vaccination of adolescent girls attending safety net clinics. Vaccine. 2012 Mar 16;30(13):2368–2375. doi: 10.1016/j.vaccine.2011.11.031.
    1. Tiro J, Sanders J, Pruitt S, Stevens C, Skinner C, Bishop W, Fuller S, Persaud D. Promoting HPV vaccination in safety-net clinics: A randomized trial. Pediatrics. 2015 Nov;136(5):850–859. doi: 10.1542/peds.2015-1536.
    1. Kahn JA, Rosenthal SL, Jin Y, Huang B, Namakydoust A, Zimet GD. Rates of human papillomavirus vaccination, attitudes about vaccination, and human papillomavirus prevalence in young women. Obstet Gynecol. 2008 May;111(5):1103–1110. doi: 10.1097/AOG.0b013e31817051fa.
    1. Conroy K, Rosenthal SL, Zimet GD, Jin Y, Bernstein DI, Glynn S, Kahn JA. Human papillomavirus vaccine uptake, predictors of vaccination, and self-reported barriers to vaccination. J Womens Health (Larchmt) 2009 Oct;18(10):1679–1686. doi: 10.1089/jwh.2008.1329.
    1. Brislin R. Back-translation for cross-cultural research. J Cross Cult Psychol. 1970;I:185–216.
    1. Nápoles-Springer AM, Santoyo-Olsson J, O'Brien H, Stewart AL. Using cognitive interviews to develop surveys in diverse populations. Med Care. 2006 Nov;44(11 Suppl 3):S21–S30. doi: 10.1097/01.mlr.0000245425.65905.1d.
    1. Gerend MA, Weibley E, Bland H. Parental response to human papillomavirus vaccine availability: Uptake and intentions. J Adolesc Health. 2009 Nov;45(5):528–531. doi: 10.1016/j.jadohealth.2009.02.006.
    1. Bastani R, Glenn BA, Tsui J, Chang LC, Marchand EJ, Taylor VM, Singhal R. Understanding suboptimal human papillomavirus vaccine uptake among ethnic minority girls. Cancer Epidemiol Biomarkers Prev. 2011 Jul;20(7):1463–1472. doi: 10.1158/1055-9965.EPI-11-0267.
    1. Opel DJ, Mangione-Smith R, Taylor JA, Korfiatis C, Wiese C, Catz S, Martin DP. Development of a survey to identify vaccine-hesitant parents: The parent attitudes about childhood vaccines survey. Hum Vaccin. 2011 Apr;7(4):419–425.
    1. Roberts JR, Thompson D, Rogacki B, Hale JJ, Jacobson RM, Opel DJ, Darden PM. Vaccine hesitancy among parents of adolescents and its association with vaccine uptake. Vaccine. 2015 Mar 30;33(14):1748–1755. doi: 10.1016/j.vaccine.2015.01.068.
    1. Tiro JA, Meissner HI, Kobrin S, Chollette V. What do women in the U.S. know about human papillomavirus and cervical cancer? Cancer Epidemiol Biomarkers Prev. 2007 Feb;16(2):288–294. doi: 10.1158/1055-9965.EPI-06-0756.
    1. Reiter PL, Brewer NT, Smith JS. Human papillomavirus knowledge and vaccine acceptability among a national sample of heterosexual men. Sex Transm Infect. 2010 Jun;86(3):241–246. doi: 10.1136/sti.2009.039065.
    1. Gerend MA, Shepherd JE. Predicting human papillomavirus vaccine uptake in young adult women: Comparing the health belief model and theory of planned behavior. Ann Behav Med. 2012 Oct;44(2):171–180. doi: 10.1007/s12160-012-9366-5.
    1. Allen JD, Mohllajee AP, Shelton RC, Othus Megan K D. Fontenot HB, Hanna R. Stage of adoption of the human papillomavirus vaccine among college women. Prev Med. 2009 May;48(5):420–425. doi: 10.1016/j.ypmed.2008.12.005.
    1. Bynum SA, Wigfall LT, Brandt HM, Richter DL, Glover SH, Hébert JR. Assessing the influence of health literacy on HIV-positive women's cervical cancer prevention knowledge and behaviors. J Cancer Educ. 2013 Jun;28(2):352–356. doi: 10.1007/s13187-013-0470-4.
    1. Gerend MA, Barley J. Human papillomavirus vaccine acceptability among young adult men. Sex Transm Dis. 2009 Jan;36(1):58–62. doi: 10.1097/OLQ.0b013e31818606fc.
    1. McRee A, Brewer NT, Reiter PL, Gottlieb SL, Smith JS. The Carolina HPV immunization attitudes and beliefs scale (CHIAS): Scale development and associations with intentions to vaccinate. Sex Transm Dis. 2010 Apr;37(4):234–239. doi: 10.1097/OLQ.0b013e3181c37e15.
    1. Richman AR, Coronado GD, Arnold LD, Fernandez ME, Glenn BA, Allen JD, Wilson KM, Brewer NT. Cognitive testing of human papillomavirus vaccine survey items for parents of adolescent girls. J Low Genit Tract Dis. 2012 Jan;16(1):16–23. doi: 10.1097/LGT.0b013e3182293a49.
    1. Gerend MA, Shepherd MA, Shepherd JE. The multidimensional nature of perceived barriers: Global versus practical barriers to HPV vaccination. Health Psychol. 2013 Apr;32(4):361–369. doi: 10.1037/a0026248.
    1. Levesque CS, Williams GC, Elliot D, Pickering MA, Bodenhamer B, Finley PJ. Validating the theoretical structure of the Treatment Self-Regulation Questionnaire (TSRQ) across three different health behaviors. Health Educ Res. 2007 Oct;22(5):691–702. doi: 10.1093/her/cyl148.
    1. Safran DG, Kosinski M, Tarlov AR, Rogers WH, Taira DH, Lieberman N, Ware JE. The Primary Care Assessment Survey: Tests of data quality and measurement performance. Med Care. 1998 May;36(5):728–739.
    1. Lerman CE, Brody DS, Caputo GC, Smith DG, Lazaro CG, Wolfson HG. Patients' Perceived Involvement in Care Scale: Relationship to attitudes about illness and medical care. J Gen Intern Med. 1990;5(1):29–33.
    1. Willis GB. Cognitive Interviewing: A Tool for Improving Questionnaire Design. Thousand Oaks, CA: Sage Publications; 2004.
    1. Lapka C, Jupka K, Wray RJ, Jacobsen H. Applying cognitive response testing in message development and pre-testing. Health Educ Res. 2008 Jun;23(3):467–476. doi: 10.1093/her/cym089.
    1. Street RL. Physicians' communication and parents' evaluations of pediatric consultations. Med Care. 1991 Nov;29(11):1146–1152.
    1. Street RL, Millay B. Analyzing patient participation in medical encounters. Health Commun. 2001;13(1):61–73. doi: 10.1207/S15327027HC1301_06.
    1. Street RL, Gordon H, Haidet P. Physicians' communication and perceptions of patients: Is it how they look, how they talk, or is it just the doctor? Soc Sci Med. 2007 Aug;65(3):586–598. doi: 10.1016/j.socscimed.2007.03.036.
    1. Smith PJ, Kennedy AM, Wooten K, Gust DA, Pickering LK. Association between health care providers' influence on parents who have concerns about vaccine safety and vaccination coverage. Pediatrics. 2006 Nov;118(5):e1287–e1292. doi: 10.1542/peds.2006-0923.
    1. Hayes AF, Krippendorff K. Answering the call for a standard reliability measure for coding data. Commun Methods Meas. 2007;1(1):77–89.
    1. Fereday J, Muir-Cochrane E. Demonstrating rigor using thematic analysis: A hybrid approach of inductive and deductive coding and theme development. Int J Qual Methods. 2006;5:1–11.
    1. Bradley EH, Curry LA, Devers KJ. Qualitative data analysis for health services research: Developing taxonomy, themes, and theory. Health Serv Res. 2007 Aug;42(4):1758–1772. doi: 10.1111/j.1475-6773.2006.00684.x.
    1. Slamecka N, Graf P. The generation effect: Delineation of a phenomenon. J Exp Psychol. 1978;4:592–604.
    1. Cordova D, Lepper M. Intrinsic motivation and the process of learning: Beneficial effects of contextualization, personalization, and choice. J Educ Psychol. 1996;88:715–730.
    1. Kiviniemi MT, Rothman AJ. Selective memory biases in individuals' memory for health-related information and behavior recommendations. Psychol Health. 2006;21(2):247–272. doi: 10.1080/14768320500098715.
    1. Wright DB. Comparing groups in a before-after design: when t test and ANCOVA produce different results. Br J Educ Psychol. 2006 Sep;76(Pt 3):663–675. doi: 10.1348/000709905X52210.
    1. Tabachnick BG, Fidell LS. Using Multivariate Statistics. 4th ed. Boston, MA: Allyn and Bacon; 2001.
    1. Gordon HS, Street RL, Sharf BF, Souchek J. Racial differences in doctors' information-giving and patients' participation. Cancer. 2006 Sep 15;107(6):1313–1320. doi: 10.1002/cncr.22122.
    1. Ogilvy Public Relations Worldwide. Centers for Disease Control Prevention HPV Health Care Provider Materials Testing Report. 2005. [2015-09-02]. .
    1. Centers for Disease Control Prevention . HPV Vaccine for Preteens and Teens. Atlanta, GA: Centers for Disease Control Prevention; 2015. [2015-09-02]. .
    1. Friedman AL, Shepeard H. Exploring the knowledge, attitudes, beliefs, and communication preferences of the general public regarding HPV: Findings from CDC focus group research and implications for practice. Health Educ Behav. 2007 Jun;34(3):471–485. doi: 10.1177/1090198106292022.
    1. Cates JR, Ortiz R, Shafer A, Romocki LS, Coyne-Beasley T. Designing messages to motivate parents to get their preteenage sons vaccinated against human papillomavirus. Perspect Sex Reprod Health. 2012 Mar;44(1):39–47. doi: 10.1363/4403912.
    1. Hull PC, Williams EA, Khabele D, Dean C, Bond B, Sanderson M. HPV vaccine use among African American girls: Qualitative formative research using a participatory social marketing approach. Gynecol Oncol. 2014 Mar;132 Suppl 1:S13–S20. doi: 10.1016/j.ygyno.2014.01.046.
    1. Hilton A, Skrutkowski M. Translating instruments into other languages: Development and testing processes. Cancer Nurs. 2002 Feb;25(1):1–7.
    1. Castro FG, Barrera M, Martinez CR. The cultural adaptation of prevention interventions: Resolving tensions between fidelity and fit. Prev Sci. 2004 Mar;5(1):41–45.
    1. Shafer A, Cates JR, Diehl SJ, Hartmann M. Asking mom: Formative research for an HPV vaccine campaign targeting mothers of adolescent girls. J Health Commun. 2011 Oct;16(9):988–1005. doi: 10.1080/10810730.2011.571343.
    1. Webb TL, Sheeran P. Does changing behavioral intentions engender behavior change? A meta-analysis of the experimental evidence. Psychol Bull. 2006 Mar;132(2):249–268. doi: 10.1037/0033-2909.132.2.249.

Source: PubMed

Patrocinadores e Colaboradores

Condições médicas

Intervenções de drogas

3
Se inscrever